Prophylactic uses of partially or fully reduced forms of hmgb1 prior to injury
AssigneeOxford University Innovation Limited
InventorsJagdeep Nanchahal, Ana Isabel Espirito Santo, Geoffrey Lee, James Chan, Nicole Horwood, Marc Feldmann
Life of this patent
Estimating the term…
Abstract
The subject invention provides a method of preventing a consequence of an anticipated injury in a subject which comprises administering to the subject a therapeutically effective amount of the fully reduced (all thiol) form of HMGB1 or a biologically active truncated form of HMGB1, so as to prevent the consequence of the anticipated injury.
Claims27
A method of preventing a consequence of an anticipated injury in a subject which comprises administering to the subject before the anticipated injury a therapeutically effective amount of the fully reduced (all thiol) form of HMGB1 or a biologically active truncated form of HMGB1, so as to prevent the consequence of the anticipated injury, wherein the subject is anticipated to be involved in an activity known to cause an increased risk of sustaining the anticipated injury and the activity is an elective surgery, a sport, or military combat.
(canceled)
5-9. (canceled)
(canceled)
14-19. (canceled)
21-27. (canceled)
29-31. (canceled)
33-39. (canceled)
Dependencies are inferred from the claim text.